美国更年期市场规模、份额和趋势分析报告：按类型、地区和细分市场预测，2025-2033 年

美国更年期疾病市场规模及趋势：

美国更年期市场规模预计在 2024 年达到 55.6 亿美元，预计到 2033 年将达到 85.8 亿美元，2025 年至 2033 年的复合年增长率为 5.0%。

经历更年期的女性数量不断增加，人们对更年期以及与更年期相关的症状的认识和教育不断提高，这些都推动了对相关产品、服务和治疗的需求。根据美国国家医学图书馆 2023 年的报告，美国每年约有 130 万名女性经历更年期，更年期通常发生在 45 至 55 岁之间。此外，人们对天然和有机更年期治疗的日益偏好，以及市场上创新产品和技术的出现，例如无荷尔蒙疗法和远端医疗服务，也促进了美国更年期市场的成长。

此外，根据美国妇女健康研究协会的数据，随着千禧世代的老化，预计美国每天约有6,000名女性将经历更年期。美国非营利美国AARP于2024年1月进行的一项调查发现，约90%的35岁及以上女性会出现更年期症状，影响她们的日常生活和工作。世界卫生组织(WHO)的数据表明，闭经通常始于45至56岁之间。然而，一小部分女性（约5%）会在40至45岁之间自然提早闭经。此外，还有一种罕见的疾病，称为原发性卵巢功能不全，仅有1%的女性会在40岁之前因永久性卵巢衰竭而完全停月经。美国国家医学图书馆的一项研究表明，某些种族背景的女性比其他地区的女性更容易提前或过早闭经。黑人和西班牙裔女性的闭经发生闭经1.4%，而白人女性仅为 1%。

目录

第一章调查方法与范围

第二章执行摘要

第三章市场变数、趋势和范围

• 市场谱系
  • 母市场分析
  • 辅助市场分析
• 美国更年期市场 - 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
  • 市场机会分析
  • 市场问题分析
• COVID-19影响分析
• 监管和报销情况
• 商业环境工具分析：美国更年期市场
  • 波特五力分析
  • PESTLE分析

第四章美国更年期市场：类型评估与趋势分析

• 美国更年期市场类型：关键要点
• 美国更年期市场：2024 年和 2033 年类型趋势和市场份额分析
• 荷尔蒙
• 非荷尔蒙
• 营养补充品

第五章美国更年期市场：区域估计与趋势分析

• 美国更年期市场（按地区）：关键要点
• 美国更年期市场：2024 年和 2033 年区域趋势和市场份额分析
• 西
• 东南
• 西南
• 中西部
• 东北

第六章 竞争态势

• 公司分类
• 企业市场分析
• 战略地图
• 公司简介
  • Pfizer Inc.
  • Novo Nordisk A/S
  • TherapeuticsMD
  • Bayer AG
  • AbbVie, Inc.
  • Pure Encapsulations, LLC.
  • PADAGIS LLC

U.S. Menopause Market Size & Trends:

The U.S. menopause market size was estimated at USD 5.56 billion in 2024 and is projected to reach USD 8.58 billion by 2033, growing at a CAGR of 5.0% from 2025 to 2033. The increasing number of women who are reaching menopause age and the rise in awareness and education and its related symptoms are resulting in a growing demand for related products, services, and treatments. According to the report published by the National Library of Medicine in 2023, approximately 1.3 million women experience menopause each year, typically between the age group of 45 to 55 in the U.S. Moreover, the increasing preference for natural and organic menopause remedies and the availability of innovative products and technologies in the market, such as hormone-free therapies and telemedicine services, are also contributing to the growth of the market in the U.S.

In addition, as per the Society for Women's health Research, as the millennial population is aging, the country has around 6,000 women are expected to enter menopause each day in the U.S. A survey conducted by AARP, a U.S.-based nonprofit organization, in January 2024, revealed that approximately 90% of women aged 35 and older experience menopausal symptoms that impact their daily lives and work activities. According to the World Health Organization (WHO), menopause typically begins between the ages of 45 to 56 years. Wherein there is a small proportion of women, approximately 5%, who experience it early, naturally which occurs between the ages of 40 and 45 years old. Furthermore, there is a rare condition known as primary ovarian insufficiency, in which only 1% of women undergo a complete stop of menstruation before the age of 40 due to permanent ovarian failure. Research from the National Library of Medicine indicates that women from certain ethnic backgrounds experience premature and early menopause more frequently than their counterparts from different communities. The incidence of premature menopause is 1.4% for Black and Hispanic women, while it is only 1% for White women.

U.S. Menopause Market Report Segmentation

This report forecasts revenue growth, country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033 for this study, Grand View Research has segmented the U.S. menopause market report based on type, country.

• Type Outlook (Revenue, USD Billion, 2021 - 2033)
• Hormonal
• Non-Hormonal
• Dietary Supplements
• Country Outlook (Revenue, USD Billion, 2021 - 2033)
• Southeast
• West
• Midwest
• Southwest
• Northeast

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources & Third-Party Perspectives
  • 1.3.4. Primary Research
  • 1.3.5. Details of Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
  • 1.5.1. Commodity Flow Analysis
• 1.6. Data Validation & Publishing
• 1.7. List of Secondary Sources
• 1.8. Research Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segmental Snapshot
• 2.3. Competitive Insights Snapshot

Chapter 3. Market Variables, Trends, and Scope

• 3.1. Market Lineage
  • 3.1.1. Parent Market Analysis
  • 3.1.2. Ancillary Market Analysis
• 3.2. U.S. Menopause Market- Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenges Analysis
• 3.3. Covid-19 Impact Analysis
• 3.4. Regulatory & Reimbursement Scenario
• 3.5. Business Environmental Tools Analysis: U.S. Menopause Market
  • 3.5.1. Porter's Five Forces Analysis
  • 3.5.2. PESTLE Analysis

Chapter 4. U.S. Menopause Market: Type Estimates & Trend Analysis

• 4.1. U.S. Menopause Market, By Type: Key Takeaways
• 4.2. U.S. Menopause Market: Type Movement & Market Share Analysis, 2024 & 2033
• 4.3. Hormonal
  • 4.3.1. Hormonal Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 4.4. Non-Hormonal
  • 4.4.1. Non-Hormonal Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 4.5. Dietary Supplements
  • 4.5.1. Dietary Supplements Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 5. U.S. Menopause Market: Country Estimates & Trend Analysis

• 5.1. U.S. Menopause Market, By Regional: Key Takeaways
• 5.2. U.S. Menopause Market: Regional Movement & Market Share Analysis, 2024 & 2033
• 5.3. West
  • 5.3.1. West Menopause Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.4. Southeast
  • 5.4.1. Southeast Menopause Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.5. Southwest
  • 5.5.1. Southwest Menopause Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.6. Midwest
  • 5.6.1. Midwest Menopause Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
• 5.7. Northeast
  • 5.7.1. Northeast Menopause Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 6. Competitive Landscape

• 6.1. Company Categorization
• 6.2. Company Market Position Analysis
• 6.3. Strategy Mapping
• 6.4. Company Profiles
  • 6.4.1. Pfizer Inc.
    • 6.4.1.1. Overview
    • 6.4.1.2. Financial Performance
    • 6.4.1.3. Product Benchmarking
    • 6.4.1.4. Strategic Initiatives
  • 6.4.2. Novo Nordisk A/S
    • 6.4.2.1. Overview
    • 6.4.2.2. Financial Performance
    • 6.4.2.3. Product Benchmarking
    • 6.4.2.4. Strategic Initiatives
  • 6.4.3. TherapeuticsMD
    • 6.4.3.1. Overview
    • 6.4.3.2. Financial Performance
    • 6.4.3.3. Product Benchmarking
    • 6.4.3.4. Strategic Initiatives
  • 6.4.4. Bayer AG
    • 6.4.4.1. Overview
    • 6.4.4.2. Financial Performance
    • 6.4.4.3. Product Benchmarking
    • 6.4.4.4. Strategic Initiatives
  • 6.4.5. AbbVie, Inc.
    • 6.4.5.1. Overview
    • 6.4.5.2. Financial Performance
    • 6.4.5.3. Product Benchmarking
    • 6.4.5.4. Strategic Initiatives
  • 6.4.6. Pure Encapsulations, LLC.
    • 6.4.6.1. Overview
    • 6.4.6.2. Financial Performance
    • 6.4.6.3. Product Benchmarking
    • 6.4.6.4. Strategic Initiatives
  • 6.4.7. PADAGIS LLC
    • 6.4.7.1. Overview
    • 6.4.7.2. Financial Performance
    • 6.4.7.3. Product Benchmarking
    • 6.4.7.4. Strategic Initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviation
• Table 3 U.S. menopause market revenue estimates and forecast, by type, 2021 - 2033 (USD Billion)
• Table 4 U.S. menopause market revenue estimates and forecast, by regional, 2021 - 2033 (USD Billion)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 U.S. menopause market: market outlook
• Fig. 9 U.S. menopause competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 U.S. menopause market driver impact
• Fig. 14 U.S. menopause market restraint impact
• Fig. 15 U.S. menopause market: Treatment movement analysis
• Fig. 16 U.S. menopause market: Treatment outlook and key takeaways
• Fig. 17 Dietary supplements market estimates and forecast, 2021 - 2033 (USD Billion)
• Fig. 18 OTC pharma products estimates and forecast, 2021 - 2033 (USD Billion)
• Fig. 19 Hormonal estimates and forecast, 2021 - 2033 (USD Billion)
• Fig. 20 Non hormonal market estimates and forecasts, 2021 - 2033 (USD Billion)